BZLF1 Expression of EBV is correlated with PARP1 Regulation on Nasopharyngeal Carcinoma Tissues

BZLF1 Expression of EBV is correlated with PARP1 Regulation on Nasopharyngeal Carcinoma Tissues

Nasopharyngeal carcinomas (NPC) is a cancer that arises in the epithelial tissue that covers the inside of the nasopharyngeal mucosa and nasopharynx. Infected Epstein Barr Virus (EBV) cell in a latent infection associated with the expression of nine latent proteins. Latent Membrane Protein 1 (LMP1)...

Full description

Bibliographic Details
Main Author:	Wahyu nur laili fajri, Ahmad Rofi'i, Fatchiyah Fatchiyah
Format:	Article
Language:	English
Published:	University of Brawijaya 2013-04-01
Series:	Journal of Tropical Life Science
Subjects:	BZLF1 CLSM EBV nasopharyngeal carcinoma PARP1
Online Access:	http://jtrolis.ub.ac.id/index.php/jtrolis/article/viewFile/48/105

Similar Items

Computational biology assisted exploration of phytochemicals derived natural inhibitors to block BZLF1 gene activation of Epstein–Bar virus in host
by: Muhammad Naveed, et al.
Published: (2024-12-01)

Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease
by: Elshafa Hassan Ahmed, et al.
Published: (2021-05-01)

EBV lytic proteins BZLF1 and BILF1 inhibit the expression of major histocompatibility complex in Raji cells
by: ZHENG Hongling, GUO Qingwei, ZHANG Wei, ZHANG Yan, HE Xingbo, YE Bing
Published: (2023-04-01)

LMP-1 and Nasopharyngeal Carcinoma (NPC)
by: Anggun Indah Budiningrum, et al.
Published: (2014-06-01)

Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma
by: Tomokazu Yoshizaki, et al.
Published: (2023-12-01)

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
by: Pok Man Hau, et al.
Published: (2020-05-01)

EBV‐LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer
by: Kousho Wakae, et al.
Published: (2020-10-01)

LMP1-EBV Gene Deletion Mutations and HLA Genotypes of Nasopharyngeal Cancer Patients in Vietnam
by: Cua Thi Hong Trinh, et al.
Published: (2023-01-01)

Genetic variations and clinical significance in young-onset nasopharyngeal cancer: Analysis of EBV interaction with cellular receptor variants and viral glycoproteins
by: Sulistyo Emantoko Dwi Putra, et al.
Published: (2025-01-01)

LMP-1 ve Nazofaringial Karsinoma
by: Anggun İndah BUDİNİNGRUM, et al.
Published: (2014-07-01)

Loss of NFBD1/MDC1 disrupts homologous recombination repair and sensitizes nasopharyngeal carcinoma cells to PARP inhibitors
by: Zhihai Wang, et al.
Published: (2019-02-01)

Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma
by: Shan-Shan Guo, et al.
Published: (2022-08-01)

EBV LMP1-C terminal binding affibody molecule downregulates MEK/ERK/p90RSK pathway and inhibits the proliferation of nasopharyngeal carcinoma cells in mouse tumor xenograft models
by: Yanru Guo, et al.
Published: (2023-01-01)

The prognostic value of integration of pretreatment serum amyloid A (SAA)–EBV DNA (S-D) grade in patients with nasopharyngeal carcinoma
by: Jianpei Li, et al.
Published: (2020-01-01)

A 3-gene signature comprising CDH4, STAT4 and EBV-encoded LMP1 for early diagnosis and predicting disease progression of nasopharyngeal carcinoma
by: Shu-Chen Liu, et al.
Published: (2023-07-01)

Primary nasopharyngeal carcinoma with cerebrospinal fluid EBV positivity: A case report and mini literature review
by: Jinli Feng, et al.
Published: (2024-03-01)

Programmed death‐ligand 1 expression in Epstein‐Barr virus positive nasopharyngeal cancer
by: Abdulhameed Alfagih, et al.
Published: (2023-06-01)

Andrographolide Inhibits Epstein–Barr Virus Lytic Reactivation in EBV-Positive Cancer Cell Lines through the Modulation of Epigenetic-Related Proteins
by: Praphatson Malat, et al.
Published: (2022-07-01)

EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis
by: Tingting Yang, et al.
Published: (2022-07-01)

Changes in plasma EBV-DNA and immune status in patients with nasopharyngeal carcinoma after treatment with intensity-modulated radiotherapy
by: Qi Chen, et al.
Published: (2019-03-01)

Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma
by: Kina Kase, et al.
Published: (2021-03-01)

A Distinct Anti-EBV DNase Profile in Patients with Undifferentiated Nasopharyngeal Carcinoma Compared to Classical Antigens
by: Hamid Melouli, et al.
Published: (2023-10-01)

Long‐term monitoring of dynamic changes in plasma EBV DNA for improved prognosis prediction of nasopharyngeal carcinoma
by: Wanxia Li, et al.
Published: (2021-02-01)

The Prognostic Values of PARP-1 Expression in Uveal Melanoma
by: Malgorzata Gajdzis, et al.
Published: (2021-01-01)

Lack of association between cigarette smoking and Epstein Barr virus reactivation in the nasopharynx in people with elevated EBV IgA antibody titres
by: Yufeng Chen, et al.
Published: (2018-02-01)

The diagnostic value of EBV-DNA and EBV-related antibodies detection for nasopharyngeal carcinoma: a meta-analysis
by: Weixing Liu, et al.
Published: (2021-03-01)

Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma
by: Ye Q, et al.
Published: (2021-07-01)

Immune cells markers within local tumor microenvironment are associated with EBV oncoprotein in nasopharyngeal cancer
by: Soehartati A. Gondhowiardjo, et al.
Published: (2022-08-01)

Genotypes of Epstein–Barr virus (EBV1/EBV2) in individuals with infectious mononucleosis in the metropolitan area of Belém, Brazil, between 2005 and 2016
by: Talita Antonia Furtado Monteiro, et al.
Published: (2020-07-01)

Prognostic value of plasma EBV DNA for nasopharyngeal cancer patients during treatment with intensity-modulated radiation therapy and concurrent chemotherapy
by: Lertbutsayanukul Chawalit, et al.
Published: (2018-04-01)

Molecular Detection of Epstein - Barr virus in Nasopharyngeal Carcinoma among Sudanese population
by: Ali Edris, et al.
Published: (2016-11-01)

Effects of oral maintenance chemotherapy and predictive value of circulating EBV DNA in metastatic nasopharyngeal carcinoma
by: Han Zhou, et al.
Published: (2020-04-01)

A Systematic Review of Epstein–Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma
by: Ana Banko, et al.
Published: (2021-08-01)

Revealing the selective mechanisms of inhibitors to PARP-1 and PARP-2 via multiple computational methods
by: Hongye Hu, et al.
Published: (2020-05-01)

HMGA2 as a functional antagonist of PARP1 inhibitors in tumor cells
by: Sabine Hombach‐Klonisch, et al.
Published: (2019-02-01)

Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells
by: Paulina Gil-Kulik, et al.
Published: (2020-05-01)

The Role of NK Cells in EBV Infection and EBV-Associated NPC
by: Yi Tian Png, et al.
Published: (2021-02-01)

Transcriptional regulation mechanism of PARP1 and its application in disease treatment
by: Yu Lu, et al.
Published: (2024-08-01)

Structurally unique PARP‐1 inhibitors for the treatment of prostate cancer
by: Ali Divan, et al.
Published: (2020-04-01)

Significance of Pre-Treatment CALLY Score Combined with EBV-DNA Levels for Prognostication in Non-Metastatic Nasopharyngeal Cancer Patients: A Clinical Perspective
by: Jiang T, et al.
Published: (2024-05-01)